Literature DB >> 18348316

Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading.

Kazutaka Nakayama1, Isao Ohsawa, Atsuko Maeda-Ohtani, Maki Murakoshi, Satoshi Horikoshi, Yasuhiko Tomino.   

Abstract

Several clinical markers correlate well with the diagnosis and prognosis of IgA nephropathy (IgAN). In the present study, we re-evaluated the usefulness of these four clinical markers for prediction of the diagnosis of patients with IgAN through a comparison between many more patients with IgAN and those with other types of renal diseases. 364 patients with IgAN and 289 with other types of renal disease were examined. An analysis was performed prior to renal biopsy, using clinical markers including, serum IgA, serum IgA/C3 ratio, number of red blood cells in urinary sediments, and urinary protein. Patients with IgAN were divided into four groups according to histopathological findings. Presence of microscopic hematuria, persistent proteinuria, high serum IgA levels, and the serum IgA/C3 ratios are useful for prediction of diagnosis of IgAN and distinguishing it from other renal diseases. Blood pressure, urinary protein, serum uric acid, renal function, and urinary sediment findings may be useful for prediction of prognostic grading in patients with IgAN. (Copyright ) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348316      PMCID: PMC6649041          DOI: 10.1002/jcla.20227

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  17 in total

1.  Clinicopathologic study on prognostic markers in IgA nephropathy.

Authors:  J Mera; S Uchida; M Nagase
Journal:  Nephron       Date:  2000-02       Impact factor: 2.847

2.  Relationship between serum IgA/C3 ratio and progression of IgA nephropathy.

Authors:  Hiroyuki Komatsu; Shouichi Fujimoto; Seiichiro Hara; Yuji Sato; Kazuhiro Yamada; Tanenao Eto
Journal:  Intern Med       Date:  2004-11       Impact factor: 1.271

3.  Urinary microscopy as seen by nephrologists.

Authors:  G B Fogazzi; S Grignani; P Colucci
Journal:  Clin Chem Lab Med       Date:  1998-12       Impact factor: 3.694

4.  Predicting progression in IgA nephropathy.

Authors:  L P Bartosik; G Lajoie; L Sugar; D C Cattran
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

Review 5.  Clinical features and natural history in adults with IgA nephropathy.

Authors:  G D'Amico
Journal:  Am J Kidney Dis       Date:  1988-11       Impact factor: 8.860

Review 6.  Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors.

Authors:  G D'Amico
Journal:  Am J Kidney Dis       Date:  2000-08       Impact factor: 8.860

7.  Current indications for renal biopsy: a questionnaire-based survey.

Authors:  G Fuiano; G Mazza; N Comi; A Caglioti; L De Nicola; C Iodice; M Andreucci; V E Andreucci
Journal:  Am J Kidney Dis       Date:  2000-03       Impact factor: 8.860

8.  Serum IgA/C3 ratio may predict diagnosis and prognostic grading in patients with IgA nephropathy.

Authors:  Chizuru Ishiguro; Yutaka Yaguchi; Kazuhiko Funabiki; Satoshi Horikoshi; Isao Shirato; Yasuhiko Tomino
Journal:  Nephron       Date:  2002-08       Impact factor: 2.847

9.  Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy.

Authors:  Atsuko Maeda; Tomohito Gohda; Kazuhiko Funabiki; Satoshi Horikoshi; Isao Shirato; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

10.  Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version.

Authors:  Yasuhiko Tomino; Hideto Sakai
Journal:  Clin Exp Nephrol       Date:  2003-06       Impact factor: 2.801

View more
  10 in total

Review 1.  Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouse.

Authors:  Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2010-11-06       Impact factor: 2.801

2.  Significance of broad distribution of electron-dense deposits in patients with IgA nephropathy.

Authors:  Gaku Kusaba; Isao Ohsawa; Masaya Ishii; Hiroyuki Inoshita; Miyuki Takagi; Chiaki Tanifuji; Kaori Takahashi; Junichi Nakamoto; Mitsutaka Yoshida; Hiroyuki Ohi; Satoshi Horikoshi; Hidetake Kurihara; Yasuhiko Tomino
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

3.  Influence of the serum levels of immunoglobulins on clinical outcomes in medical intensive-care patients.

Authors:  C Geier; J Schröder; A Tamm; S Dietz; S Nuding; K Holder; Ö Khandanpour; K Werdan; H Ebelt
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-12-17       Impact factor: 0.840

4.  Impact of Body Mass Index on Progression of IgA Nephropathy Among Japanese Patients.

Authors:  Mamiko Shimamoto; Isao Ohsawa; Hiyori Suzuki; Atsuko Hisada; Seiji Nagamachi; Daisuke Honda; Hiroyuki Inoshita; Yoshio Shimizu; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

5.  Clinical and histopathological spectrum of IgA nephropathy in Kuwait.

Authors:  Amal Abdel Ghani; Salah Al Waheeb; Ekhlas Al Homoud; Bassam Al Helal; Naser Hussain
Journal:  Ann Saudi Med       Date:  2011 Mar-Apr       Impact factor: 1.526

6.  High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.

Authors:  Wen-Yu Gong; Man Liu; Dan Luo; Fan-Na Liu; Liang-Hong Yin; Yuan-Qing Li; Jun Zhang; Hui Peng
Journal:  BMC Nephrol       Date:  2019-04-30       Impact factor: 2.388

7.  Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease?

Authors:  Jorge Rojas-Rivera; Gema Fernández-Juárez; Manuel Praga
Journal:  Clin Kidney J       Date:  2015-09-24

8.  Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy.

Authors:  Yusuke Suzuki; Keiichi Matsuzaki; Hitoshi Suzuki; Keiko Okazaki; Hiroyuki Yanagawa; Norio Ieiri; Mitsuhiro Sato; Toshinobu Sato; Yoshio Taguma; Joe Matsuoka; Satoshi Horikoshi; Jan Novak; Osamu Hotta; Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2014-01-30       Impact factor: 2.801

9.  Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy.

Authors:  Yan Ouyang; Jingyuan Xie; Meng Yang; Xiaoyan Zhang; Hong Ren; Weiming Wang; Nan Chen
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

Review 10.  Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management.

Authors:  Haresh Selvaskandan; Sufang Shi; Sara Twaij; Chee Kay Cheung; Jonathan Barratt
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.